MARINUS PHARMACEUTICALS INC Contracts & Agreements
86 Contracts & Agreements
- Business Finance (29 contracts)
- Business Operations (14)
- Human Resources (35)
- Intellectual Property (2)
- Real Estate (2)
- Uncategorized (4)
- Form of Amended and Restated Indemnification Agreement (Non-VC Directors) (Filed With SEC on March 5, 2024)
- Description of the Registrants Securities (Filed With SEC on March 5, 2024)
- Amendment No. 1 to the Equity Distribution Agreement, dated as of March 31, 2023, by and between Marinus Pharmaceuticals, Inc. and JMP Securities LLC (Filed With SEC on March 31, 2023)
- Collaboration and Supply Agreement, dated November 16, 2022, between Marinus Pharmaceuticals, Inc. and Tenacia Biotechnology (Shanghai) Co., Ltd (Filed With SEC on March 9, 2023)
- Employment Agreement, effective November 9, 2020, between Marinus Pharmaceuticals, Inc. and Christina Shafer (Filed With SEC on March 9, 2023)
- Form of Amended and Restated Indemnification Agreement (Non-VC Directors) (Filed With SEC on March 9, 2023)
- Underwriting Agreement, dated November 7, 2022, by and among Marinus Pharmaceuticals, Inc., SVB Securities LLC, RBC Capital Markets, LLC and Cantor Fitzgerald & Co (Filed With SEC on November 10, 2022)
- Form of Pre-funded Warrant to Purchase Common Stock (Filed With SEC on November 10, 2022)
- Limited Consent and First Amendment to Credit Agreement, dated October 28, 2022, by and among Marinus Pharmaceuticals, Inc., as Grantor, and Oaktree Fund Administration, LLC, as... (Filed With SEC on November 7, 2022)
- Security Agreement dated October 28, 2022, by and among Marinus Pharmaceuticals, Inc. and Sagard Healthcare Royalty Partners, LP (Filed With SEC on November 7, 2022)
- Revenue Interest Financing Agreement, dated October 28, 2022, by and between Marinus Pharmaceuticals, Inc. and Sagard Healthcare Royalty Partners, LP (Filed With SEC on November 7, 2022)
- Amendment No. 2, dated September 21, 2022, by and between Marinus Pharmaceuticals, Inc. and the Biomedical Advanced Research and Development Authority, a division of the U.S.... (Filed With SEC on September 23, 2022)
- Asset Purchase Agreement, dated July 13, 2022, by and between Marinus Pharmaceuticals, Inc. and Novo Nordisk Inc (Filed With SEC on July 14, 2022)
- Letter Agreement re: Amendment to Tranche C Commitment, dated May 23, 2022, by and among Marinus Pharmaceuticals, Inc., as Borrower, Oaktree Fund Administration, LLC, as... (Filed With SEC on May 25, 2022)
- Amendment, dated March 29, 2022, by and between Marinus Pharmaceuticals, Inc. and the Biomedical Advanced Research and Development Authority, a division of the U.S. Department of... (Filed With SEC on March 31, 2022)
- Form of Restricted Stock Unit Agreement containing a Sell to Cover Election for Employees granted as an Inducement Award, under the Marinus Pharmaceuticals, Inc. 2014 Equity... (Filed With SEC on March 24, 2022)
- Form of Restricted Stock Unit Agreement for Employees granted as an Inducement Award, under the Marinus Pharmaceuticals, Inc. 2014 Equity Incentive Plan, as amended (Filed With SEC on March 24, 2022)
- Form of Restricted Stock Unit Agreement containing a Sell to Cover Election for Employees under the Marinus Pharmaceuticals, Inc. 2014 Equity Incentive Plan, as amended (Filed With SEC on March 24, 2022)
- Form of Amended and Restated Indemnification Agreement (Non-VC Directors) (Filed With SEC on March 24, 2022)
- Description of the Registrants Securities (Filed With SEC on March 24, 2022)
- License Agreement, dated March 1, 2022, by and between Marinus Pharmaceuticals, Inc. and Ovid Therapeutics Inc (Filed With SEC on March 3, 2022)
- Form of Nonqualified Stock Option Agreement for Non-Employee Directors under the Marinus Pharmaceuticals, Inc. 2014 Equity Incentive Plan, as amended (Filed With SEC on November 9, 2021)
- Form of Nonqualified Stock Option Agreement for Employees granted as an Inducement Award (Filed With SEC on November 9, 2021)
- Form of Restricted Stock Unit Agreement for Employees under the Marinus Pharmaceuticals, Inc. 2014 Equity Incentive Plan, as amended (Filed With SEC on November 9, 2021)
- Form of Restricted Stock Unit Agreement for Non-Employee Directors under the Marinus Pharmaceuticals, Inc. 2014 Equity Incentive Plan, as amended (Filed With SEC on November 9, 2021)
- Form of Nonqualified Stock Option Agreement for Employees under the Marinus Pharmaceuticals, Inc. 2014 Equity Incentive Plan, as amended (Filed With SEC on November 9, 2021)
- Form of Incentive Stock Option Agreement for Employees under the Marinus Pharmaceuticals, Inc. 2014 Equity Incentive Plan, as amended (Filed With SEC on November 9, 2021)
- Collaboration Agreement, dated as of July 30, 2021, by and between Marinus Pharmaceuticals, Inc. and Orion Corporation (Filed With SEC on November 9, 2021)
- First Amendment to Executive Employment Agreement, by and between Marinus Pharmaceuticals, Inc. and Steven Pfanstiel, MBA, CMA dated April 9, 2021 (Filed With SEC on April 13, 2021)
- Separation and Consulting Agreement and General Release, dated as of March 9, 2021, between the Company and Edward F. Smith (Filed With SEC on March 9, 2021)
- Employment Agreement dated as of June 15, 2020 between the Company and Martha Manning (Filed With SEC on March 9, 2021)
- Form of Amended and Restated Indemnification Agreement (Non-VC Directors) (Filed With SEC on March 9, 2021)
- Employment Agreement, effective as of April 12, 2021, between the Company and Steven Pfanstiel (Filed With SEC on March 9, 2021)
- Description of the Registrants Securities (Filed With SEC on March 9, 2021)
- Underwriting Agreement, dated December 8, 2020, by and between Marinus Pharmaceuticals, Inc. and Cantor Fitzgerald & Co (Filed With SEC on December 9, 2020)
- Marinus Pharmaceuticals, Inc. 2014 Equity Incentive Plan, as amended (Filed With SEC on November 9, 2020)
- Underwriting Agreement, dated May 28, 2020, by and among Marinus Pharmaceuticals, Inc., Cowen and Company, LLC and Cantor Fitzgerald & Co (Filed With SEC on May 29, 2020)
- Description of the Registrants Securities (Filed With SEC on March 16, 2020)
- Form of Amended and Restated Indemnification Agreement (Non-VC Directors) (Filed With SEC on March 16, 2020)
- Underwriting Agreement dated December 11, 2019 (Filed With SEC on December 13, 2019)
- Securities Purchase Agreement dated December 11, 2019 between the Company and the Investors listed therein (Filed With SEC on December 13, 2019)
- Employment Agreement dated as of October 25, 2019 between Joe Hulihan, M.D. and Marinus Pharmaceuticals, Inc (Filed With SEC on October 29, 2019)
- Marinus Pharmaceuticals, Inc. 2014 Equity Incentive Plan, as amended, effective as of May 7, 2019 (Filed With SEC on August 8, 2019)
- Amended and Restated Employment Agreement dated as of August 6, 2019, between the Company and Scott Braunstein, M.D (Filed With SEC on August 8, 2019)
- Employment Agreement dated as of February 26, 2019 between the Company and Scott Braunstein (Filed With SEC on March 12, 2019)
- Underwriting Agreement, dated as of December 12, 2018, between the Company and Jefferies LLC and Leerink Partners LLC, as the Representatives of the several underwriters (Filed With SEC on December 14, 2018)
- Second Amendment to Lease agreement dated as of December 7, 2018 between Radnor Properties-SDC, L.P. and Marinus Pharmaceuticals, Inc, amending Lease agreement, as amended, dated... (Filed With SEC on December 7, 2018)
- Equity Distribution Agreement dated as of October 31, 2017 between the Company and JMP Securities LLC (Filed With SEC on October 31, 2017)
- Underwriting Agreement, dated as of September 15, 2017, between the Company and JMP Securities LLC, as the Representative of the several underwriters (Filed With SEC on September 15, 2017)
- MARINUS PHARMACEUTICALS, INC. 2014 EQUITY INCENTIVE PLAN, AS AMENDED (Filed With SEC on August 1, 2017)
- EMPLOYMENT AGREEMENT (Filed With SEC on April 12, 2017)
- SUPPLY AGREEMENT (Filed With SEC on April 6, 2017)
- LICENSE AGREEMENT (Filed With SEC on April 6, 2017)
- MARINUS PHARMACEUTICALS, INC. CHANGE IN CONTROL SEVERANCE PLAN (Filed With SEC on November 8, 2016)
- EXHIBIT 10.3 AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on August 9, 2016)
- Exhibit 10.1 AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on August 9, 2016)
- AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on August 9, 2016)
- FOURTH AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on May 2, 2016)
- FIRST AMENDMENT TO LEASE (Filed With SEC on January 4, 2016)
- 5,000,000 Shares Marinus Pharmaceuticals, Inc. UNDERWRITING AGREEMENT (Filed With SEC on November 6, 2015)
- THIRD AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on October 29, 2015)
- SECOND AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on October 29, 2015)
- EMPLOYMENT AGREEMENT (Filed With SEC on March 12, 2015)
- AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on March 12, 2015)
- AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on March 12, 2015)
- MARINUS PHARMACEUTICALS, INC. 2014 EQUITY INCENTIVE PLAN (Filed With SEC on March 12, 2015)
- INCENTIVE STOCK OPTION AGREEMENT (Filed With SEC on March 12, 2015)
- INCENTIVE STOCK OPTION AGREEMENT (Filed With SEC on March 12, 2015)
- NONQUALIFIED STOCK OPTION AGREEMENT (Filed With SEC on March 12, 2015)
- FIRST AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on December 3, 2014)
- MARINUS PHARMACEUTICALS, INC. 2014 EQUITY INCENTIVE PLAN (Filed With SEC on September 12, 2014)
- [ ] Shares MARINUS PHARMACEUTICALS, INC. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on July 18, 2014)
- FORM OF MARINUS PHARMACEUTICALS, INC. THIRD AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT , 2014 (Filed With SEC on July 9, 2014)
- MARINUS PHARMACEUTICALS, INC. FORM OF NON-QUALIFIED STOCK OPTION AGREEMENT (Filed With SEC on May 12, 2014)
- WARRANT TO PURCHASE STOCK (Filed With SEC on May 12, 2014)
- MARINUS PHARMACEUTICALS, INC. 2005 STOCK OPTION AND INCENTIVE PLAN (Filed With SEC on May 12, 2014)
- EMPLOYMENT AGREEMENT (Filed With SEC on May 12, 2014)
- THIS DOCUMENT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST PURSUANT TO RULE 406 UNDER THE SECURITIES ACT OF 1933, AS AMENDED. REDACTED MATERIAL IS... (Filed With SEC on May 12, 2014)
- AMENDED AND RESTATED INDEMNIFICATION AGREEMENT (Filed With SEC on May 12, 2014)
- AMENDED AND RESTATED INDEMNIFICATION AGREEMENT (Filed With SEC on May 12, 2014)
- MARINUS PHARMACEUTICALS, INC. LOAN AND SECURITY AGREEMENT 1 (Filed With SEC on May 12, 2014)
- CLINICAL DEVELOPMENT AND COLLABORATION AGREEMENT (Filed With SEC on May 12, 2014)
- ASSIGNMENT AND ASSUMPTION AGREEMENT (Filed With SEC on May 12, 2014)
- THIS DOCUMENT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST PURSUANT TO RULE 406 UNDER THE SECURITIES ACT OF 1933, AS AMENDED. REDACTED MATERIAL IS... (Filed With SEC on May 12, 2014)
- EMPLOYMENT AGREEMENT (Filed With SEC on May 12, 2014)
- EMPLOYMENT AGREEMENT (Filed With SEC on May 12, 2014)